STO Equity Snapshot

HAMLET-B Weekly Equity Report

Hamlet BioPharma AB ser. B

Interactive chart JSON snapshot
Latest Close 7.15 SEK 12 Jun 2026
1W Return 1.9% latest completed week
4W Return -1.8% short-term follow-through
12W Return -0.6% quarterly tape
Trend Breadth 92.3% 48 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
Company Brief

What the company does

Hamlet BioPharma AB (publ) engages in the development of drugs for the treatment and prevention of cancer in Sweden. It is developing HAMLET, a tumoricidal protein-lipid complex formed by two generally regarded as safe (GRAS) molecules found in human milk for various oncology markets, including colon, bladder, and cervix cancers, as well as primary or metastatic brain tumors. The company's products under development include Alpha1H for the treatment of bladder cancer and brain tumors; and BAMLET for the treatment of colon and oral cancer. Hamlet BioPharma AB (publ) was formerly known as Hamlet Pharma AB …

Snapshot

What the weekly tape is saying

HAMLET-B closed the latest completed week at 7.15 SEK. The 4-week return is -1.8% and the 12-week return is -0.6%. Trend Signal is active, Market Dynamics is -0.41. Setup signature: Balanced read with a 53/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 10.2%
Volume 0.9x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 96 Persistence of active Trend Signal over the last year and current streak.
Momentum 45 Blend of 4-week and 12-week follow-through.
Dynamics 29 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 83 Relative leadership and short-term RS change.
Volume 38 Participation compared with the 13-week volume baseline.
Risk Control 29 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
6.49 SEK
Vs Trend Line
10.2%
Fair Value
3.98 SEK
Vs Fair Value
79.8%
52W High
8.96 SEK
52W Low
3.35 SEK
Drawdown
-20.2%
Range Position
67.8%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 1.9%
4W -1.8%
12W -0.6%
26W 30.2%
52W 84.3%

Trend read

Active Streak
14 weeks
52W Active Weeks
48
52W Active Breadth
92.3%
Sector Scope
SE Healthcare
Sector Rank
50 of 158
Sector Percentile
68.8%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.41
4W MD Change
-173.2%
Relative Strength
11.93
4W RS Change
-40.7%
Expectation
Negative
Probability
44.89%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
583.0K
13W Average
636.7K
52W Average
886.1K
Vs 13W
0.9x
Vs 52W
0.7x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
6.5%
52W Volatility
8.3%
Upside Weeks
26
Downside Weeks
26
Downside Breadth
50.0%
Avg Gain / Loss
7.4% / -4.4%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
STO
Country
SE
Sector
Healthcare
Industry
Biotechnology
Currency
SEK
Market Cap
1.4B

Opportunity signals

  • Trend Signal is active with a 14-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 7.15 SEK 1.9% 6.49 SEK 3.98 SEK -0.41 11.93 583.0K On
5 Jun 2026 7.02 SEK -5.9% 6.43 SEK 3.95 SEK -0.22 10.54 265.2K On
29 May 2026 7.46 SEK -1.5% 6.34 SEK 3.92 SEK 0.07 17.42 414.7K On
22 May 2026 7.57 SEK 4.0% 6.25 SEK 3.89 SEK 0.34 19.68 596.0K On
15 May 2026 7.28 SEK -4.6% 6.17 SEK 3.86 SEK 0.56 20.12 728.7K On
8 May 2026 7.63 SEK -6.8% 6.10 SEK 3.83 SEK 0.86 25.38 433.8K On
1 May 2026 8.19 SEK 2.4% 6.02 SEK 3.80 SEK 1.11 36.31 259.6K On
24 Apr 2026 8.00 SEK -2.0% 5.91 SEK 3.77 SEK 1.28 32.62 548.7K On
17 Apr 2026 8.16 SEK -6.7% 5.82 SEK 3.73 SEK 1.37 32.82 694.7K On
10 Apr 2026 8.75 SEK -0.9% 5.73 SEK 3.70 SEK 1.45 46.81 774.5K On
3 Apr 2026 8.83 SEK 19.0% 5.63 SEK 3.66 SEK 1.50 56.92 1.2M On
27 Mar 2026 7.42 SEK 3.2% 5.54 SEK 3.63 SEK 1.41 38.50 487.2K On
20 Mar 2026 7.19 SEK -1.5% 5.51 SEK 3.60 SEK 1.33 35.55 1.3M On
13 Mar 2026 7.30 SEK 23.5% 5.46 SEK 3.58 SEK 0.91 31.93 2.0M On